Major Adverse Cardiac and Cerebrovascular Events After the Ross Procedure

Abstract

Although longer follow-up of patients who undergo Ross operation is needed, the present series confirms that the autograft procedure is a valid option to treat aortic valve disease in selected patients. The nonreinforced full root technique and preoperative aortic regurgitation are predictors for autograft failure and warrant further consideration. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00708409.

Pulmonary autograft in aortic position: is everything known?

“…These findings were directionally similar to those reported on the basis of the long-term results in other studies (11,13,30). Thus, it appears that the failure risk of pulmonary autograft root expansion associated with Ross operation is offset by a low occurrence of thromboembolic complications, bleeding, nonstructural valve failure, and endocarditis compared with other aortic valve substitutes that translates into increasing clinical benefit to at least 15 years.…”

Patient Age at the Ross Operation in Children Influences Aortic Root Dimensions and Aortic Regurgitation

“…20,21 Stabilizing techniques to prevent failing of the autograft are efficacious in adolescents and adults. [10][11][12] In small children, stabilizing the autograft is disadvantageous, since it prevents the growth of the valve.…”

Role of Primary Bacterial Contamination of a Pulmonary Homograft for Ross Operation: Report of a Case and Review of the Literature

“…Late endocarditis was observed in 38 out of 1420 adult patients (0.38% per patient-year). 4 No general approach exists for homograft or autograft endocarditis, but prompt surgical reinterventions have been recommended for embolizing forms. 5 In subtle forms, both diagnosis and therapy constitute serious problems.…”